| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |